Beta interferon, an anti-inflammatory drug that has already been approved for treatment of multiple sclerosis, is being paired with remdesivir in the latest phase of a federal coronavirus trial, The New York Times reports.
The remdesivir-focused study has found it can quicken the recovery time of COVID-19 patients, but researchers are seeking to boost its effects by combining it with other treatments. Beta interferon is the second drug to get the call — the results of the study's second phase which involved an anti-inflammatory arthritis drug are still being evaluated — and scientists are hopeful, per the Times.
For starters, it's already on the market, albeit for a different purpose. Either way, it's shown promise against the new coronavirus, killing it (along the SARS and MERS coronaviruses) in lab studies. Additionally, tests in the United Kingdom and Hong Kong showed the drug performed better among COVID-19 patients than the placebo it was up against. Both those studies were too small to come away with anything definitive, but the U.S. trial should be large enough to get a better sense of its ability. Read more at The New York Times.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Regal Scottish castle hotelsThe Week Recommends These rural retreats are perfect for a Traitors-inspired cosy winter break
-
Will the public buy Rachel Reeves’ tax rises?Today’s Big Question The Chancellor refused to rule out tax increases in her televised address, and is set to reverse pledges made in the election manifesto
-
Margaret Atwood’s ‘deliciously naughty’ memoirIn the Spotlight ‘Bean-spilling’ book by The Handmaid’s Tale author is ‘immensely readable’
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
